当前位置: 首页 >> 检索结果
共有 7480 条符合本次的查询结果, 用时 2.8726547 秒

1. Glucocorticoid or immunosuppressives withdrawal in SLE in remission: that is the question… the only question?

作者: Guillermo Ruiz-Irastorza.
来源: Rheumatology (Oxford). 2025年

2. Patients' experiences of managing their rare rheumatic disease.

作者: Emma Dures.;Celia Almeida.;Sadia Janjua.;Andrew Hunt.;Jen Orme.;Peter C Lanyon.;Nicola Walsh.;Joanna C Robson.
来源: Rheumatology (Oxford). 2025年
The rare autoimmune rheumatic diseases (RAIRDs) include systemic lupus erythematosus (lupus), systemic vasculitis, inflammatory myositis, systemic sclerosis, and Sjögren's Disease. The objective of the study is to understand patients' experiences of living with and managing their RAIRD.

3. Anti-HMGCR myopathy: observed ethnic differences in disease and disease outcomes in New Zealand.

作者: Hamish Anderson.;Ke Li Chow.;John O'Donnell.
来源: Rheumatology (Oxford). 2025年
Anti-HMGCR myopathy is an immune-mediated necrotizing myopathy strongly associated with statin use in adults. Polynesians have a higher incidence of anti-HMGCR myopathy in New Zealand (NZ), but ethnic differences in phenotype and outcome are not known.

4. Avacopan may not independently reduce ANCA titres in ANCA-Associated vasculitis: a retrospective analysis of 57 patients.

作者: Motoki Takeuchi.;Yoshiyuki Abe.;Masahiro Kogami.;Ayako Makiyama.;Ken Yamaji.;Naoto Tamura.
来源: Rheumatology (Oxford). 2025年

5. Whole-body MRI in patients with arthralgia or inflammatory arthritis after exposure to immune checkpoint inhibitors: a single-centre prospective imaging study.

作者: Kate Harnden.;Navkiran Sidhu.;Emma Rowbotham.;Laurence Duquenne.;Sana Sharrack.;Keith Howell.;Dominic Bertham.;Kerem Abacar.;Paul Emery.;Dennis McGonagle.;Kulveer Mankia.
来源: Lancet Rheumatol. 2025年
Musculoskeletal adverse events due to immune checkpoint inhibitors are common and can present clinically as inflammatory arthritis, polymyalgia rheumatica, or arthralgia. The pathoanatomy of musculoskeletal adverse events related to immune checkpoint inhibitors remains undefined, with a paucity of available imaging data. We aimed to investigate the whole-body imaging phenotype of arthralgia and inflammatory arthritis following exposure to immune checkpoint inhibitors, to fully characterise the pattern of inflammation in these patients and subsequently inform clinical management.

6. Occupational therapist-led versus rheumatologist-led care in people with hand osteoarthritis in Norway: an open-label, multicentre, randomised controlled, non-inferiority trial.

作者: Annikka Polster.;Unni Olsen.;Lars Asphaug.;Kjetil Bergsmark.;Barbara Christensen.;Ida K Haugen.;Toril Hennig.;Merete Hermann-Eriksen.;Åshild Hove.;Trine Sjøvold.;Joe Sexton.;Anne Therese Tveter.;Ingvild Kjeken.
来源: Lancet Rheumatol. 2025年
Hand osteoarthritis is a common musculoskeletal disease with a rising prevalence due to increased life expectancy. Because the disease is diagnosed on the basis of clinical examination and the first choice of treatment is non-pharmacological, it is not a high-risk condition. We aimed to assess the non-inferiority and cost-effectiveness of occupational therapist-led care for hand osteoarthritis compared with rheumatologist-led care.

7. What can imaging teach us about immune checkpoint inhibitor-induced arthritis?

作者: Alice Tison.;Anne R Bass.
来源: Lancet Rheumatol. 2025年

8. Re-evaluation of MEFV carriers previously diagnosed with familial Mediterranean fever: a colchicine discontinuation study.

作者: Veysel Cam.;Dilara Unal.;Erdal Sag.;Yagmur Bayindir.;Emil Aliyev.;Hulya Ercan Emreol.;Mehmet Orhan Erkan.;Ozlem Necipoglu Banak.;Hazel Delal Dara Kar.;Ozge Basaran.;Yelda Bilginer.;Seza Ozen.
来源: Rheumatology (Oxford). 2025年
Familial Mediterranean Fever (FMF) is an autoinflammatory disease associated with mutations in the MEFV gene. While typically inherited in an autosomal recessive pattern, heterozygous individuals may also exhibit FMF symptoms, often with a milder disease course. The long-term management of colchicine therapy in heterozygous patients, particularly decisions regarding its discontinuation, remains a clinical challenge.

9. Bidirectional association of rheumatoid arthritis and inflammatory bowel diseases: a large-scale prospective cohort study.

作者: Yijun Chen.;Qian Zhang.;Si Liu.;Shengtao Zhu.;Jing Wu.;Shutian Zhang.;Peng Li.;Shanshan Wu.
来源: Rheumatology (Oxford). 2025年
to investigate the bidirectional prospective association between inflammatory bowel disease (IBD) and rheumatoid arthritis (RA) in a large-scale, long-term follow-up, population-based cohort.

10. Lupus serology: off target but still relevant to the treat-to-target strategy in systemic lupus erythematosus.

作者: Matteo Piga.
来源: Rheumatology (Oxford). 2025年

11. Ruxolitinib for refractory lung granulomatosis in two pediatric patients.

作者: Marine Michelet.;Benjamin Fournier.;Benjamin Terrier.;Dominique Valeyre.;Jean-François Bernaudin.;Cécile Lozach.;Karine Brochard.;Naziha Khen-Dunlop.;Christophe Delacourt.;Laureline Berteloot.;Anna Vigier.;Dominique Berrebi.;Brigitte Bader-Meunier.;David Drummond.
来源: Rheumatology (Oxford). 2025年

12. Comparison of quantitative lung ultrasound scores with automated quantitative CT: to overcome the ultrasound limitations.

作者: Davide Mohammad Reza Beigi.;Greta Pellegrino.;Nicholas Landini.;Marco Emanuele Diana.;Gregorino Paone.;Ilaria Bisconti.;Francesca Romana Di Ciommo.;Marius Cadar.;Elena Platania.;Jacopo Landro.;Simona Truglia.;Valeria Panebianco.;Fabrizio Conti.;Valeria Riccieri.
来源: Rheumatology (Oxford). 2025年
Lung ultrasound (LUS) is emerging as a valuable tool for assessing systemic sclerosis-associated interstitial lung disease (SSc-ILD), although it traditionally explores only superficial lung regions. Building upon our preliminary findings, this study investigated correlations between quantitative LUS scores and automated quantitative computed tomography (qCT) measurement of ILD extent, including both superficial and deeper lung involvement.

13. Global variations in artificial intelligence-generated information on juvenile idiopathic arthritis.

作者: Saverio La Bella.;Deniz Bayraktar.;Annamaria Porreca.;Linda C Li.;Marina Attanasi.;Emil Aliyev.;Angela Nyangore Migowa.;Christiaan Scott.;Darpan R Thakare.;Yagmur Bayindir.;Alessandro Consolaro.;Brian M Feldman.;Seza Ozen.
来源: Rheumatology (Oxford). 2025年
We aimed to evaluate similarities and variations of information provided by Large Language Models (LLMs) across diverse world regions by analyzing responses to validated questions on oligoarticular juvenile idiopathic arthritis (oJIA).

14. Executive summary: The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis.

作者: Kathryn Biddle.;Judith Jade.;Harold Wilson-Morkeh.;Madura Adikari.;Chadwan Al Yaghchi.;Zoi Anastasa.;Neil Basu.;Paul Brogan.;Dimitrios Chanouzas.;Shouvik Dass.;David D'Cruz.;Marcos Martinez Del Pero.;Emmandeep Dhillon.;Georgina Ducker.;Siân Griffin.;Rosemary J Hollick.;David Jackson.;Catherine King.;Matko Marlais.;Alice Mason.;Stephen McAdoo.;Devesh Mewar.;Janice Mooney.;Eleana Ntatsaki.;Fiona Pearce.;Benjamin Rhodes.;Hitasha Rupani.;Alan Salama.;Salman Siddiqui.;Rona Smith.;Lorraine Harper.; .
来源: Rheumatology (Oxford). 2025年

15. The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis.

作者: Kathryn Biddle.;Judith Jade.;Harold Wilson-Morkeh.;Madura Adikari.;Chadwan Al Yaghchi.;Zoi Anastasa.;Neil Basu.;Paul Brogan.;Dimitrios Chanouzas.;Shouvik Dass.;David D'Cruz.;Marcos Martinez Del Pero.;Emmandeep Dhillon.;Georgina Ducker.;Siân Griffin.;Rosemary J Hollick.;David Jackson.;Catherine King.;Matko Marlais.;Alice Mason.;Stephen McAdoo.;Devesh Mewar.;Janice Mooney.;Eleana Ntatsaki.;Fiona Pearce.;Benjamin Rhodes.;Hitasha Rupani.;Alan Salama.;Salman Siddiqui.;Rona Smith.;Lorraine Harper.; .
来源: Rheumatology (Oxford). 2025年
ANCA-associated vasculitis (AAV) is comprised of three specific conditions: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). Since the publication of the last British Society for Rheumatology (BSR) and British Health Professionals in Rheumatology (BHPR) guideline for the management of adults with AAV in 2014, a plethora of randomized controlled trials, additional research and recommendations have provided novel insights into how the management of AAV can be optimized, thus improving patient quality of life. The BSR AAV Working Group (WG) reviewed published guidelines, undertook a systematic literature review and utilized expertise from specialist vasculitis centres across the UK and patient representatives to formulate a list of 26 recommendations with corresponding strength of agreement (SOA) scores. Recommendations were updated from the published 2014 BSR and BHPR guideline. The 26 recommendations encompassed five key domains: 1. Treatment for GPA and MPA; 2. Management of subglottic stenosis and ear, nose and throat (ENT) manifestations of AAV; 3. Management and treatment for EGPA; 4. Service specifications; 5. Patient education and support. These recommendations provide an update on care delivery of AAV based on current evidence and specialist opinion. In addition, we have provided research and audit recommendations to support equitable access to care and improve health outcomes. The lay summary that accompanies this abstract can be found in Supplementary Data S1, available at Rheumatology online.

16. A case-control study on autoimmune polyendocrine syndromes in patients with systemic lupus erythematosus.

作者: Elda Piovani.;Giorgia Gozzoli.;Silvia Della Pina.;Claudia Barison.;Chiara Orlandi.;Elisa Gatta.;Cesare Tomasi.;Micaela Fredi.;Carlo Cappelli.;Franco Franceschini.
来源: Rheumatology (Oxford). 2025年
This study aimed to investigate the prevalence of Autoimmune Polyendocrine Syndromes (APS) in patients with Systemic Lupus Erythematosus (SLE) and to assess whether APS predicts higher disease activity or worse outcomes.

17. 2023 International Rome consensus for the nomenclature of Sjögren disease.

作者: Manuel Ramos-Casals.;Alan N Baer.;María Del Pilar Brito-Zerón.;Katherine M Hammitt.;Coralie Bouillot.;Soledad Retamozo.;Alison Mackey.;David Yarowsky.;Breck Turner.;Jaime Blanck.;Benjamin A Fisher.;Esen K Akpek.;Chiara Baldini.;Hendrika Bootsma.;Simon J Bowman.;Thomas Dörner.;Leslie Laing.;Scott M Lieberman.;Xavier Mariette.;Stephen C Pflugfelder.;Vidya Sankar.;Antoni Sisó-Almirall.;Athanasios G Tzioufas.;Juan-Manuel Anaya.;Berkan Armağan.;Michele Bombardieri.;Steven Carsons.;Salvatore de Vita.;Robert I Fox.;Roberto Gerli.;Roberto Giacomelli.;Jacques Eric Gottenberg.;Gabriela Hernández-Molina.;Roland Jonsson.;Aike Kruize.;Seung-Ki Kwok.;Xiaomei Li.;Sara S McCoy.;Wan-Fai Ng.;Peter Olsson.;Maureen Rischmueller.;Alain Saraux.;R Hal Scofield.;Valéria Valim.;Claudio Vitali.;Frederick Vivino.;Marie Wahren-Herlenius.;Haralampos M Moutsopoulos.; .
来源: Nat Rev Rheumatol. 2025年
Nomenclature for the disease widely known as Sjögren syndrome has proven unsatisfactory. Patients have perceived 'syndrome' as indicative of a vague collection of symptoms, prompting the Sjögren's Foundation to abandon the term. Furthermore, the traditional distinction between 'primary' and 'secondary' forms fails to account for the complex interplay between overlapping autoimmune diseases. Following a bibliometric analysis, systematic literature review and a Delphi consensus process with equal involvement of professional and patient representatives, five recommendations are now issued. First, the term 'Sjögren disease' should replace 'Sjögren syndrome'. Second, the acronym 'SjD' should be used as an abbreviation for 'Sjögren disease'. Third, the descriptor 'associated' should be used in lieu of 'secondary' for Sjögren disease occurring in association with a second systemic autoimmune disease for which classification criteria are fulfilled. Fourth, Sjögren disease is the preferred terminology in common parlance and in clinical diagnosis, without differentiation as to primary and associated forms. Fifth, the differentiation between primary and associated Sjögren is recommended for scientific studies to define a homogeneous population. In conclusion, the consensus endorses 'Sjögren disease' as the official nomenclature to acknowledge the distinct pathogenesis of this disorder and to improve clarity in both clinical practice and research.

18. Methotrexate does not improve knee OA.

作者: Sarah Onuora.
来源: Nat Rev Rheumatol. 2025年

19. Methotrexate as first-line therapy for pulmonary sarcoidosis.

作者: Sarah Onuora.
来源: Nat Rev Rheumatol. 2025年

20. Baricitinib in rheumatoid arthritis-interstitial lung disease: national multicenter study of 72 patients and literature review.

作者: Ana Serrano-Combarro.;Belén Atienza-Mateo.;Adrián Martín-Gutiérrez.;Jesús Loarce Martos.;César Antonio Egües Dubuc.;Marta Pastor Mena.;Rafael B Melero-Gonzalez.;María Martín López.;Natalia Mena Vázquez.;Carmen Carrasco-Cubero.;Carolina Pérez García.;Andrea García Valle.;Gema Bonilla.;Juan María Blanco Madrigal.;Uxue Astigarraga-Urquia.;Nuria Vegas Revenga.;Lorena Pérez Albadalejo.;Rafaela Ortega Castro.;Deseada Palma Sánchez.;Ana María Fernández Ortiz.;Patricia López Viejo.;María López Lasanta.;Marta Garijo Bufort.;Ivette Casafont Solé.;José Ramón Lamua-Riazuelo.;Ignacio Braña Abascal.;Virginia Ruiz-Esquide.;Evelin Cervantes Perez.;Bryan-Josué Flores Robles.;María Paz Martínez-Vidal.;Juan Moreno Morales.;Ana Urruticoechea-Arana.;José Rosas.;Delia Fernández Lozano.;David Castro Corredor.;Iván Ferraz-Amaro.;Santos Castañeda.;Ricardo Blanco.; .
来源: Rheumatology (Oxford). 2025年
To assess the effectiveness and safety of baricitinib (BARI) in Rheumatoid Arthritis-interstitial lung disease (RA-ILD) in clinical practice.
共有 7480 条符合本次的查询结果, 用时 2.8726547 秒